Home Nucleus Pharmaceuticals Netherlands Influenza Drug Market to 2032

Netherlands Influenza Drug Market to 2032

Overview

The Netherlands Influenza Drug Market is expected to reach a 220.62 USD Million by 2032 and is projected to grow at a CAGR of 6.53% from 2025 to 2032.

Revenue, 2024 (USD Million)
146.65
Forecast, 2032 (USD Million)
220.62
CAGR, 2024 - 2032
6.53%
Report Coverage
Netherlands

Netherlands Influenza Drug Market 2018-2032 USD Million

Netherlands Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 146.65 USD Million
  • Projected Market Size (2032): 220.62 USD Million
  • CAGR (2025-2032): 6.53%

Key Findings of Netherlands Influenza Drug Market

  • The Netherlands Influenza Drug Market was valued at 146.65 USD Million in 2024.
  • The Netherlands Influenza Drug Market is likely to grow at a CAGR of 6.53% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 256.17 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.27% during the forecast period from 2024 to 2032.

Netherlands Influenza Drug Market Scope

Netherlands Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Treatment
  • Drugs
  • Vaccines

Netherlands Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 146.65 USD Million
Market Value in 2032 220.62 USD Million
CAGR (2025-2032) 6.53%
Historic Data 2016-2023
Market Segments Covered Type,Route of Administration,Age,End User,Distribution Channel,Treatment

Regional Insights:

  • Leading Market (2024-2032): Netherlands, leading in terms of revenue 146.65 USD Million in 2024
    • Key Country: Netherlands, leading in terms of revenue with value of 146.65 USD Million in 2024.

Segments and Scope

  • Netherlands Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 71.10 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 7.01 % in forecast period 2025-2032.
  • Netherlands Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 65.61 USD Million in the year 2024.
    • Oral is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 7.27 % in forecast period 2025-2032.
  • Netherlands Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 75.45 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 6.96 % in forecast period 2025-2032.
  • Netherlands Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 107.22 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 6.69 % in forecast period 2025-2032.
  • Netherlands Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 83.36 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 6.84 % in forecast period 2025-2032.
  • Netherlands Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in Netherlands Influenza Drug Market to 2032 with a revenue of 256.17 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in Netherlands Influenza Drug Market to 2032 with a Growth rate of 6.56 % in forecast period 2025-2032.

Netherlands Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
Netherlands Influenza Drug Market Company Share Analysis

Netherlands Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Netherlands Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

Netherlands Influenza Drug Market Company Profiling

Netherlands Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Netherlands Influenza Drug Market is segmented based on Segmentation Type,Route of Administration,Age,End User,Distribution Channel,Treatment.
Netherlands Influenza Drug Market was valued at USD 146.65(Revenue in USD Million) in 2022.
Netherlands Influenza Drug Market is projected to grow at a CAGR of 6.53% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the Netherlands Influenza Drug Market, holding a largest market share of 256.17 USD Million in 2024

Netherlands Influenza Drug Market Scope

Netherlands Influenza Drug Market Segmentation & Scope
Type
  • Influenza C
  • Influenza B
  • Influenza A
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Adults
  • Pediatrics
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Treatment
  • Drugs
  • Vaccines
Frequently Asked Questions
The Netherlands Influenza Drug Market is segmented based on Segmentation Type,Route of Administration,Age,End User,Distribution Channel,Treatment.
Netherlands Influenza Drug Market was valued at USD 146.65(Revenue in USD Million) in 2022.
Netherlands Influenza Drug Market is projected to grow at a CAGR of 6.53% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Influenza Drug Market for final year is USD 220.62 (USD Million).

Netherlands Influenza Drug Market Company Profiling

Netherlands Influenza Drug Market Company Profiling
Frequently Asked Questions
The Netherlands Influenza Drug Market is segmented based on Segmentation Type,Route of Administration,Age,End User,Distribution Channel,Treatment.
Netherlands Influenza Drug Market was valued at USD 146.65(Revenue in USD Million) in 2022.
Netherlands Influenza Drug Market is projected to grow at a CAGR of 6.53% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Influenza Drug Market for final year is USD 220.62 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES